ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Cash Flow Reinvestment Rate
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow Reinvestment Rate of 0.08x as of September 2025, reinvesting CN¥23.89 Million (capex CN¥23.89 Million ) from operating cash flow of CN¥288.83 Million. See ZhuZhou QianJin Pharmaceutical Co Ltd (600479) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2002–2025)
Historical reinvestment intensity for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. For the full cash flow conversion analysis, see ZhuZhou QianJin Pharmaceutical Co Ltd cash conversion from operations.
Annual Cash Flow Reinvestment Rate for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year capital reinvestment analysis for ZhuZhou QianJin Pharmaceutical Co Ltd. See how financially flexible is ZhuZhou QianJin Pharmaceutical Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.94x | CN¥933.22 Million | CN¥480.24 Million | CN¥124.17 Million | ▲ +4.5% |
| 2024 | 1.86x | CN¥741.57 Million | CN¥398.77 Million | CN¥47.32 Million | ▲ +18.7% |
| 2023 | 1.57x | CN¥694.07 Million | CN¥443.12 Million | CN¥43.99 Million | ▲ +633.7% |
| 2022 | 0.21x | CN¥156.58 Million | CN¥733.47 Million | CN¥34.43 Million | ▲ +6.8% |
| 2021 | 0.20x | CN¥97.06 Million | CN¥485.57 Million | CN¥71.88 Million | ▼ -89.1% |
| 2020 | 1.83x | CN¥990.84 Million | CN¥542.37 Million | CN¥97.24 Million | ▲ +33.0% |
| 2019 | 1.37x | CN¥213.57 Million | CN¥155.49 Million | CN¥40.61 Million | ▲ +44.2% |
| 2018 | 0.95x | CN¥365.30 Million | CN¥383.47 Million | CN¥46.39 Million | ▼ -40.9% |
| 2017 | 1.61x | CN¥457.16 Million | CN¥283.47 Million | CN¥57.30 Million | ▲ +12.4% |
| 2016 | 1.43x | CN¥202.06 Million | CN¥140.88 Million | CN¥81.50 Million | ▼ -61.2% |
| 2015 | 3.69x | CN¥249.32 Million | CN¥67.48 Million | CN¥84.47 Million | ▲ +926.7% |
| 2014 | 0.36x | CN¥65.97 Million | CN¥183.34 Million | CN¥65.97 Million | ▼ -41.2% |
| 2013 | 0.61x | CN¥84.26 Million | CN¥137.63 Million | CN¥84.26 Million | ▼ -52.7% |
| 2012 | 1.30x | CN¥256.26 Million | CN¥197.82 Million | CN¥256.26 Million | ▼ -54.2% |
| 2011 | 2.83x | CN¥63.87 Million | CN¥22.58 Million | CN¥63.87 Million | ▲ +89.4% |
| 2010 | 1.49x | CN¥58.44 Million | CN¥39.13 Million | CN¥58.44 Million | ▼ -10.9% |
| 2009 | 1.68x | CN¥123.31 Million | CN¥73.54 Million | CN¥123.31 Million | ▼ -34.5% |
| 2008 | 2.56x | CN¥95.30 Million | CN¥37.20 Million | CN¥95.30 Million | ▲ +801.0% |
| 2007 | 0.28x | CN¥22.53 Million | CN¥79.26 Million | CN¥22.53 Million | ▲ +59.7% |
| 2006 | 0.18x | CN¥21.39 Million | CN¥120.12 Million | CN¥21.39 Million | ▼ -18.6% |
| 2005 | 0.22x | CN¥16.74 Million | CN¥76.50 Million | CN¥16.74 Million | ▼ -92.9% |
| 2004 | 3.06x | CN¥56.50 Million | CN¥18.45 Million | CN¥56.50 Million | ▲ +358.2% |
| 2003 | 0.67x | CN¥34.05 Million | CN¥50.96 Million | CN¥34.05 Million | ▼ -93.1% |
| 2002 | 9.75x | CN¥59.24 Million | CN¥6.07 Million | CN¥59.24 Million | — |